|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K2039/505 | (2013.01) |
| C07K 16/28 | (2006.01) | ||
| G01N 33/566 | (2006.01) | ||
| C07K2317/21 | (2013.01) | ||
| G01N 33/68 | (2006.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61P 37/02 | (2006.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/94 | (2013.01) | ||
| G01N 33/566 | (2013.01) | ||
| G01N 33/6854 | (2013.01) | ||
| C07K2317/567 | (2013.01) | ||
| C07K 16/283 | (2013.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 17/02 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 21/04 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 7/04 | (2018.01) | ||
| A61P 7/06 | (2018.01) |
| (11) | Patento numeris | 3137504 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15785500.8 |
| Europos patento paraiškos padavimo data | 2015-04-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-05-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2015/004424 |
| Data | 2015-04-30 |
| (87) | Numeris | WO 2015/167293 |
| Data | 2015-11-05 |
| (30) | Numeris | Data | Šalis |
| 201461986742 P | 2014-04-30 | US |
| (72) |
KIM, Sung Wuk , KR
PARK, Seung Kook , KR
JEONG, Jae Kap , KR
AHN, Hyea Kyung , KR
KIM, Min Sun , KR
KIM, Eun Sun , KR
YONG, Hae-Young , KR
SHIN, Dongok , KR
SONG, Yeon Jung , KR
YOO, Tae Hyoung , KR
|
| (73) |
Hanall Biopharma Co., Ltd. ,
43 Sangseodang 1-gil
Daedeok-gu, Daejeon 306-120,
KR
|
| (54) | ANTIBODY BINDING TO FCRN FOR TREATING AUTOIMMUNE DISEASES |
| ANTIBODY BINDING TO FCRN FOR TREATING AUTOIMMUNE DISEASES |